EFFECT OF DAPAGLIFLOZIN, SITAGLIPTIN AND METFORMIN COMBINATION ON SOME METABLIC RISK FACTORS IN IRAQI PATIENTS WITH TYPE-2 DIABETES MELLITUS. Neuropsychopharmacologia Hungarica, [S. l.], v. 22, n. 1, p. 204–209, 2024. Disponível em: http://neuropsychopharmacologiahungarica.com/index.php/NPPH/article/view/17.. Acesso em: 18 jun. 2024.